Myers Industries Inc. (MYE) Drops 5.29% on January 15

Equities Staff  |

Myers Industries Inc. (MYE) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 5.29% to $11.27, a loss of $-0.63 per share. Starting at an opening price of $11.54 a share, the stock traded between $11.10 and $11.74 over the course of the trading day. Volume was 51,595 shares over 569 trades, against an average daily volume of 106,750 shares and a total float of 30.14 million.

The losses send Myers Industries Inc. down to a market cap of $339.68 million. In the last year, Myers Industries Inc. has traded between $20.10 and $11.80, and its 50-day SMA is currently $14.19 and 200-day SMA is $15.34.

The stock has a P/E Ratio of 51.7.

Myers Industries Inc manufactures a range of polymer products for industrial, agricultural, automotive, commercial and consumer markets. It also manufactures plastic reusable material handling containers and pallets.

Myers Industries Inc. is based out of Akron, OH and has some 3,241 employees. Its CEO is R. David Banyard.

For a complete fundamental analysis analysis of Myers Industries Inc., check out’s Stock Valuation Analysis report for MYE. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.